Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ESPRESPR
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ESPERION THERAPEUTICS INC NE

GEODE CAPITAL MANAGEMENT, LLC holds 6.6M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $21M as of 2026-Q2. The position was increased (+11.3% shares). ESPR represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$21M

Current Shares

6.6M

Total Value Change

-$4.4M

Total Shares Change

+6.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.6M
+11.3%
$21M0.0%$3.16
32
2026-Q1
Increased
6M
+3.8%
$16.3M0.0%$2.91
29
2025-Q4
Increased
5.7M
+20.8%
$21.2M0.0%$3.69
34
2025-Q3
Increased
4.8M
+3.6%
$12.6M0.0%$2.64
29
2025-Q2
Increased
4.6M
+3.1%
$4.5M0.0%$0.99
28
2025-Q1
Increased
4.4M
+2.5%
$6.4M0.0%$1.50
28
2024-Q4
Increased
4.3M
+0.2%
$9.5M0.0%$2.15
28
2024-Q3
Increased
4.3M
+4.1%
$7.1M0.0%$1.68
28
2024-Q2
Increased
4.2M
+137.3%
$9.2M0.0%$2.22
45
2024-Q1
Increased
1.8M
+57.6%
$4.7M0.0%$2.68
38
2023-Q4
Increased
1.1M
+14.6%
$3.3M0.0%$2.99
30
2023-Q3
Increased
970,238
+17.8%
$951,0830.0%$0.98
29
2023-Q2
Decreased
823,507
-37.6%
$1.1M0.0%$1.34
0
2023-Q1
Increased
1.3M
+3.2%
$2.1M0.0%$1.67
27
2022-Q4
Increased
1.3M
+13.5%
$8M0.0%$6.23
31
2022-Q3
Increased
1.1M
+2.9%
$7.6M0.0%$6.84
28
2022-Q2
Decreased
1.1M
-1.4%
$7M0.0%$6.67
0
2022-Q1
Increased
1.1M
+34.1%
$5.2M0.0%$4.89
35
2021-Q4
Increased
828,196
+142.3%
$4.1M0.0%$4.96
43
2021-Q3
Decreased
341,871
-24.2%
$4.1M0.0%$12.44
0
2021-Q2
Increased
450,965
+0.5%
$9.5M0.0%$21.13
28
2021-Q1
Increased
448,663
+10.0%
$12.6M0.0%$27.44
31
2020-Q4
Increased
407,872
+2.5%
$10.6M0.0%$28.15
28
2020-Q3
Increased
397,961
+2.5%
$14.8M0.0%$37.46
29
2020-Q2
Increased
388,417
+4.6%
$19.9M0.0%$47.64
30
2020-Q1
Decreased
371,416
-46.3%
$11.7M0.0%$33.98
0
2019-Q4
Increased
692,152
+96.0%
$41.3M0.0%$59.82
47
2019-Q3
Increased
353,175
+1.2%
$12.9M0.0%$37.78
28
2019-Q2
Increased
349,046
+18.4%
$16.2M0.0%$46.52
33
2019-Q1
Decreased
294,714
-46.5%
$11.8M0.0%$40.15
0
2018-Q4
New
550,820
-
$25.3M0.0%$44.17
40

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used